Journal of Emergency Health Care
Formerly known as: International Journal of Medical Investigation
Volume 6, Issue 4 (12-2017)
J Emerg Health Care 2017, 6(4): 138-143 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Sadeghnezhad R, Babaei hatkehlouei M, Golpour M, Jafarpour H. Hyper immunoglobulin-M Syndrome in children. J Emerg Health Care 2017; 6 (4) :138-143
URL: http://intjmi.com/article-1-289-en.html
URL: http://intjmi.com/article-1-289-en.html
Associated Professor, Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Abstract: (7836 Views)
Introduction: Hyper immunoglobulin-M syndrome (HIGM) is a rare, x-linked recessive inherited disorder with Increased or normal serum IgM and decreased IgA, IgG and IgE and normal peripheral B cells. In this disease, we have defect in class switch recombination (CSR) and somatic hyper mutation that is caused by defects including the enzymes required for CSR and SHM. (SHM) Methods: To update about HIGM, PubMed and Google Scholar database were searched for term, X linked Hyper IgM syndrome and CD40 ligand. In our first search, we received about 90 updated articles, and then we distributed these articles among the authors. After reading the articles and sharing together, finally 33 articles were selected that fully related to the topic as references. Findings: In conclusion, HIGM is rare disease that starts early in life with lifelong recurrent attacks of various infections by a variety of symptoms, including lymph Adenopathy, vomiting, diarrhea, skin lesion and abdominal pain. Allogenic hematopoietic cell transplantation and BMT can be effective in these patients. Conclusion: In conclusion, HIGM is rare disease that starts early in life with lifelong recurrent attacks of various Infections by a variety of symptoms, including lymphadenopathy, vomiting, diarrhea, skin lesions and abdominal pain. Allogenic hematopoietic cell transplantation and BMT can be effective in these patients.
References
1. 1. MK C Gilmour, D Walshe, and C M Cale, Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-Ig M.
2. Lougaris V, Badolato R, Ferrari S, et al. Hyper immunoglobulin M due to CD40 deficiency: clinical molecular, and immunological features. Immunological Reviews 2005;203(1):48-66.
3. Cooper MD, Faulk WP, Fudenberg HH, et al. Meeting report of the second international workshop on primary immunodeficiency disease in man held in St. Clin Immunol Immunopathol 1974;2(3):416-45.
4. Winkelstein JA, Marino MC, Ochs H, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003;82:373-84.
5. kwan SP, Kunkel L, Bruns G, et al. Mapping of the X-linked agammaglobulinemia locus by use of restriction fragment length polymorphism. J Clin Invest 1986;77:649–52.
6. Lee WI, Torgerson TR, Schumacher MJ, et al. Molecular analysis of a large cohort ofpatients with the hyper immunoglobulin M (IgM) syndrome. Blood 2005;105:1881-90.
7. Ferrari S, Giliani S, Insalaco A, et al. Mutations in CD40 gene causes an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 2001;98:12614-9.
8. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper IgM syndrome. J Pediatrics 1997;131:47-54.
9. Minegishi Y, Lavoie A, Cunningham-Rundles C, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 2000;97:203-10.
10. Jain A, Ma CA, Liu S, et al. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001;2:223-8.
11. Revy P, Muto T, Levy Y, et al, Durandy A. Activationinduced cytidine deaminase (AID) deficiency causes the autosomal recessive form of hyper-IgM syndrome (HIGM2). Cell 2000;102:565-75.
12. Imai K, Catalan N, Plebani A, et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class switch recombination. J Clin Invest 2003;112:136-42.
13. Kutukculer N, Moratto D, Aydinok Y, et al. Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency. J Pediatr 2003; 142:194
14. Mazzolari E, Lanzi G, Forino C, et al. First report of successful stem cell transplantation in a child with CD40 deficiency. Bone Marrow Transplant 2007; 40:279.
15. Lanzi G, Ferrari S, Vihinen M, et al. Different molecular behavior of CD40 mutants causing hyper-IgM syndrome. Blood 2010; 116:5867.
16. Imai K, Slupphaug G, Lee WI, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 2003; 4:1023.
17. Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol 2000;120:399-405.
18. Aghamohammadi A, Parvaneh N, Rezaei N, et al. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol 2009; 29:769.
19. Seyama K, Nonoyama S, Gangsaas I, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 1998;92:2421-34.
20. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509–16.
21. Gallerani I, Innocenti DD, Coronella G, et al. Cutaneous sarcoid-like granulomas in a patient with X-linked hyper-IgM syndrome. Pediatr Dermatol 2004;21:39-43.
22. Hayward AR, Levy J, Facchett, et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997;158:977–83.
23. Schuster A, Apfelstedt-Sylla E, Pusch CM, et al. Autoimmune retinopathy with RPE hypersensitivity and ‘negative ERG’ in X-linked hyper-IgM syndrome. Ocul Immunol Inflamm 2005;13:235-43
24. Goldman AS, Ritzman SE, Houston EW, et al. Dysgammaglobulinemia antibody deficiency syndrome: increased gamma-M globulins and decreased gamma-G and gamma-A globulins. J Pediatr 1967;70:16–27.
25. O’Gorman MRG, Zaas D, Paniagua M, et al. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyperIgM syndrome patients and carriers. Clin Immunol immunopathol 1997;85:172-81.
26. Allen RC, Armitage RJ, Conley ME, et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993;259:990-3.
27. Padayachee M, Feighery C, Finn A, et al. Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 1992;14(2):551-3.
28. Durandy A, Revy P, Imai K, et al. Hyperimmunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 2005;203:67-79.
29. Hadžic N, Pagliuca A, Rela M, et al. Correction of the hyper-IgM syndrome after liver and bone marrow transplantation. N Engl J Med 2000;321:320-4.
30. Thomas C, de Saint Basile G, Le Deist F, et al. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 1995;333:426-9.
31. Khawaja K, Gennery AR, Flood TJ, et al. Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch Dis Child 2001;84:50811.
32. Tsuji Y, Imai K, Kajiwara M, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006;37:469- 77.
33. Tomizawa D, Imai K, Ito S, et al. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience. Am J Hematol 2004; 76:33-39.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |